BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Takeda Pharmaceutical
TAK
$53.4B
| $28.2M | ﹤0.01% |
1,675,527
+307,522
| +22% | +$5.23M |
|
3077
Puma Biotechnology
PBYI
$403M
| $28.1M | ﹤0.01% |
3,065,764
-34,830
| -1% | -$353K |
|
3078
iShares MSCI Chile ETF
ECH
$1.05B
| $28.1M | ﹤0.01% |
970,540
+912,253
| +1,565% | +$28.6M |
|
|
BPYU
3079
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $28.1M | ﹤0.01% |
1,488,244
-324,487
| -18% | -$5.94M |
|
3080
Farmers National Banc Corp
FMNB
$940M
| $28.1M | ﹤0.01% |
1,808,679
+21,570
| +1% | +$362K |
|
|
LKFT
3081
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
| $28.1M | ﹤0.01% |
407,175
+346,013
| +566% | +$26.4M |
|
3082
Willdan Group
WLDN
$1.16B
| $28M | ﹤0.01% |
743,172
-43,706
| -6% | -$1.69M |
|
3083
Cartesian Therapeutics
RNAC
$245M
| $28M | ﹤0.01% |
223,033
+14,963
| +7% | +$1.78M |
|
|
MILE
3084
DELISTED
Metromile, Inc. Common Stock
MILE
| $28M | ﹤0.01% |
3,055,084
+1,722,866
| +129% | +$15.4M |
|
3085
Caesarstone
CSTE
$81.3M
| $27.9M | ﹤0.01% |
1,893,401
+18,529
| +1% | +$280K |
|
|
ADVM
3086
DELISTED
Adverum Biotechnologies
ADVM
| $27.9M | ﹤0.01% |
798,312
+75,963
| +11% | +$4.09M |
|
3087
OneWater Marine
ONEW
$212M
| $27.9M | ﹤0.01% |
664,458
+15,990
| +2% | +$742K |
|
3088
Design Therapeutics
DSGN
$847M
| $27.9M | ﹤0.01% |
1,403,342
+612,323
| +77% | +$15.5M |
|
|
ONTF
3089
DELISTED
ON24
ONTF
| $27.9M | ﹤0.01% |
785,757
-136,601
| -15% | -$5.34M |
|
3090
iShares Russell 2000 Growth ETF
IWO
$15B
| $27.9M | ﹤0.01% |
89,414
-336,761
| -79% | -$101M |
|
3091
United States Lime & Minerals
USLM
$3.36B
| $27.8M | ﹤0.01% |
998,855
-13,895
| -1% | -$391K |
|
|
CTO
3092
CTO Realty Growth
CTO
$810M
| $27.8M | ﹤0.01% |
1,556,100
+140,064
| +10% | +$2.48M |
|
3093
Praxis Precision Medicines
PRAX
$8.87B
| $27.7M | ﹤0.01% |
100,932
+20,395
| +25% | +$7.3M |
|
3094
Digimarc Corp
DMRC
$160M
| $27.6M | ﹤0.01% |
824,956
-42,560
| -5% | -$1.4M |
|
3095
Rocky Brands
RCKY
$374M
| $27.6M | ﹤0.01% |
496,454
-49,388
| -9% | -$2.78M |
|
3096
Atomera
ATOM
$204M
| $27.6M | ﹤0.01% |
1,287,313
+28,934
| +2% | +$594K |
|
3097
TC Energy
TRP
$67.5B
| $27.5M | ﹤0.01% |
556,028
+52,422
| +10% | +$2.62M |
|
3098
Blue Bird Corp
BLBD
$2.42B
| $27.5M | ﹤0.01% |
1,106,053
-93,122
| -8% | -$2.45M |
|
3099
Telefônica Brasil
VIV
$19.6B
| $27.5M | ﹤0.01% |
3,232,430
-176,945
| -5% | -$1.49M |
|
|
CMBM
3100
DELISTED
Cambium Networks
CMBM
| $27.3M | ﹤0.01% |
564,254
+57,335
| +11% | +$3.06M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.